Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1558-1570
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1558
Table 2 Perioperative outcomes, n (%) or median (interquartile range)

RALAR, n = 111
LALAR, n = 111
P value
Conversion to laparotomy02 (1.8)0.4982
Approximate intraoperative blood loss (mL)50 (20-50)50 (30-50)0.276
Intraoperative blood transfusion4 (3.6)3 (2.7)1.0001
Distal resection margin1.0002
Involved01 (0.9)
Harvested lymph nodes14 (11-16)13 (11-17)0.627
Harvested positive lymph nodes0 (0-1)0 (0-1)0.317
Duration of surgery (min)187 (160-215)185 (155-230)0.977
Intraoperative dose of sufentanil (μg/kg/min)0.0050 (0.0040-0.0062)0.0048 (0.0040-0.0064)0.948
Time to first flatus (d)2(2-2)3 (3-3)0.000
Time to first fluid diet (d)4 (3-4)5 (4-6)0.001
Postoperative indwelling catheter time (d)2 (1-3)4 (3-5)0.000
Total cost of hospitalization (dollars)10777 (10780-11850)10550 (8766-11715)0.012
Length of hospital stay after surgery (d)5 (5-7)7 (6-8)0.009
Readmission within 30 d after operation1 (0.9)1 (0.9)1.0001
Reoperation within 30 d after operation01 (0.9)1.0002